Showing results (1-10 of 382) with videos related to
Sort By:
Pageof 39
Neuroepidemiology|August 22, 2008
Clinical parameters to predict response to interferon in relapsing multiple sclerosisA Fromont, M Debouverie, G Le Teuff, et al.Neuroepidemiology|July 11, 2006
The prognostic value of initial relapses on the evolution of disability in patients with relapsing-remitting multiple sclerosisC Binquet, C Quantin, G Le Teuff, et al.Neuroepidemiology|January 12, 2007
Disability evolution in multiple sclerosis: how to deal with missing transition times in the Markov model?V Petiot, C Quantin, G Le Teuff, et al.Revue Neurologique|May 19, 2009
[Epidemiology of multiple sclerosis: The special situation in France]A Fromont, C Binquet, L Clerc, et al.European Journal of Epidemiology|December 7, 2005
A population-based assessment of the prognostic value of the CD19 positive lymphocyte count in B-cell chronic lymphocytic leukemia using Cox and Markov modelsR Cailliod, C Quantin, P M Carli, et al.Studies in Health Technology and Informatics|December 11, 2003
Law and standards faced to market rules in health information securityF A Allaert, G Le Teuff, C QuantinMethods of Information in Medicine|January 10, 2006
Improving model robustness with bootstrapping -- application to optimal discriminant analysis for ordinal responses (ODAO)G Le Teuff, C Quantin, A Venot, et al.Revue Neurologique|May 27, 2014
[Cost of multiple sclerosis in France]A Fromont, M-N Lehanneur, F Rollot, et al.Epidemiology and Infection|January 13, 2009
Markov modelling of HIV infection evolution in the HAART eraC Binquet, G Le Teuff, M Abrahamovicz, et al.Revue D'Epidemiologie Et De Sante Publique|January 1, 1990
[The Cox model: limitations and extensions]C Quantin, B Asselain, T MoreauPageof 39